Embla Medical hf
Research Embla Medical hf (EMBLA) on Bullrun: market cap DKK 12.78B, P/E 20.9. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEMBLA
- ExchangeCO
- CountryIceland
- SectorHealthcare
- IndustryMedical Devices
- CurrencyDKK
- Market capDKK 12.78B
- P/E20.9
- Financial periodQ2 2026
- RevenueUSD 258.57M
- Net incomeUSD 29.23M
- Free cash flowUSD 31.12M
- Gross margin63.4%
Valuation Snapshot
latest market cap is DKK 12.78B; P/E is 20.9.
Peer valuation comparison
Latest P/E is 20.94x versus a Healthcare sector median of 24.34x (14.0% below).
Latest P/E is 20.94x versus a Iceland median of 17.42x (20.2% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | DKK 12.78B | 20.9 | n/a | n/a |
About Embla Medical hf
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products, such as microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Embla Medical hf's market cap?
Embla Medical hf's market capitalization is DKK 12.78B.
What is Embla Medical hf's P/E ratio?
Embla Medical hf's price-to-earnings (P/E) ratio is 20.9.
What does Embla Medical hf do?
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products, such as microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints.